Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$336M |
| 2 |
Visa
V
|
+$287M |
| 3 |
Union Pacific
UNP
|
+$279M |
| 4 |
Microsoft
MSFT
|
+$277M |
| 5 |
Mastercard
MA
|
+$261M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$441M |
| 2 |
Cognizant
CTSH
|
+$273M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$268M |
| 4 |
Eli Lilly
LLY
|
+$262M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$252M |
Sector Composition
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.23% |
| 4 | Industrials | 11.1% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
SelectQuote
SLQT
$339M
| $358K | ﹤0.01% |
532,340
-451,449
| -46% | -$303K |
|
|
AGS
3302
DELISTED
PlayAGS
AGS
| $357K | ﹤0.01% |
70,057
-44
| -0.1% | -$224 |
|
3303
BCB Bancorp
BCBP
$149M
| $357K | ﹤0.01% |
19,850
-63,282
| -76% | -$1.14M |
|
|
ACCD
3304
DELISTED
Accolade, Inc. Common Stock
ACCD
| $357K | ﹤0.01% |
45,799
-287,981
| -86% | -$2.24M |
|
3305
Aurinia Pharmaceuticals
AUPH
$1.61B
| $357K | ﹤0.01% |
82,583
-5,868
| -7% | -$25.4K |
|
|
BCOV
3306
DELISTED
Brightcove, Inc.
BCOV
| $356K | ﹤0.01% |
68,145
+41,390
| +155% | +$216K |
|
3307
Evolution Petroleum
EPM
$179M
| $354K | ﹤0.01% |
46,903
-237
| -0.5% | -$1.79K |
|
|
VZIO
3308
DELISTED
VIZIO Holding Corp.
VZIO
| $352K | ﹤0.01% |
47,555
-6,510
| -12% | -$48.2K |
|
|
SJIV
3309
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
| $352K | ﹤0.01% |
5,100
| – | – |
|
3310
Blue Foundry Bancorp
BLFY
$200M
| $352K | ﹤0.01% |
27,362
-96
| -0.3% | -$1.23K |
|
3311
ACV Auctions
ACVA
$1.8B
| $351K | ﹤0.01% |
42,716
-2,269
| -5% | -$18.6K |
|
3312
Excelerate Energy
EE
$759M
| $350K | ﹤0.01% |
+13,981
| New | +$350K |
|
|
INBX
3313
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $349K | ﹤0.01% |
14,152
-255
| -2% | -$6.28K |
|
3314
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$630M
| $348K | ﹤0.01% |
38,516
-195
| -0.5% | -$1.76K |
|
|
API
3315
Agora
API
$337M
| $347K | ﹤0.01% |
88,873
-6,343
| -7% | -$24.8K |
|
3316
Protagonist Therapeutics
PTGX
$3.59B
| $344K | ﹤0.01% |
31,552
+2,828
| +10% | +$30.9K |
|
3317
Recursion Pharmaceuticals
RXRX
$1.98B
| $344K | ﹤0.01% |
44,620
-332
| -0.7% | -$2.56K |
|
3318
Universal Technical Institute
UTI
$1.48B
| $343K | ﹤0.01% |
51,012
+29,008
| +132% | +$195K |
|
3319
Navigator Holdings
NVGS
$1.1B
| $341K | ﹤0.01% |
28,552
+68
| +0.2% | +$813 |
|
3320
Byrna Technologies
BYRN
$471M
| $341K | ﹤0.01% |
43,515
-46,490
| -52% | -$364K |
|
3321
Invesco BuyBack Achievers ETF
PKW
$1.47B
| $341K | ﹤0.01% |
3,987
-4,729
| -54% | -$405K |
|
3322
Medallion Financial
MFIN
$244M
| $339K | ﹤0.01% |
47,534
-240
| -0.5% | -$1.71K |
|
3323
Invesco International BuyBack Achievers ETF
IPKW
$342M
| $339K | ﹤0.01% |
10,142
-12,303
| -55% | -$412K |
|
3324
Gulfport Energy Corp
GPOR
$3.02B
| $337K | ﹤0.01% |
4,581
-2,915
| -39% | -$215K |
|
3325
Kymera Therapeutics
KYMR
$3.11B
| $337K | ﹤0.01% |
13,493
-3
| -0% | -$75 |
|